Works matching IS 15747891 AND DT 2023 AND VI 17 AND IP 8

Results: 17

Neoantigens in cancer immunotherapy: quantity vs. quality.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1457, doi. 10.1002/1878-0261.13483

By:

Wolf, Yochai;
Sameuls, Yardena

Publication type:

Article

Retraction statement: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition.

Published in:: Molecular Oncology, 2023, v. 17, n. 8, p. 1692, doi. 10.1002/1878-0261.13482
Publication type:: Article

Analyzing the role of cancer‐associated fibroblast activation on macrophage polarization.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1492, doi. 10.1002/1878-0261.13454

By:

Bruch‐Oms, Marina;
Olivera‐Salguero, Rubén;
Mazzolini, Rocco;
del Valle‐Pérez, Beatriz;
Mayo‐González, Paula;
Beteta, Ángel;
Peña, Raúl;
García de Herreros, Antonio

Publication type:

Article

Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1460, doi. 10.1002/1878-0261.13453

By:

Dufrusine, Beatrice;
Capone, Emily;
Ponziani, Sara;
Lattanzio, Rossano;
Lanuti, Paola;
Giansanti, Francesco;
De Laurenzi, Vincenzo;
Iacobelli, Stefano;
Ippoliti, Rodolfo;
Mangiola, Annunziato;
Trevisi, Gianluca;
Sala, Gianluca

Publication type:

Article

Dual VEGFA/BRAF targeting boosts PD‐1 blockade in melanoma through GM‐CSF‐mediated infiltration of M1 macrophages.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1474, doi. 10.1002/1878-0261.13450

By:

Comunanza, Valentina;
Gigliotti, Chiara;
Lamba, Simona;
Doronzo, Gabriella;
Vallariello, Edoardo;
Martin, Valentina;
Isella, Claudio;
Medico, Enzo;
Bardelli, Alberto;
Sangiolo, Dario;
Di Nicolantonio, Federica;
Bussolino, Federico

Publication type:

Article

Pancreatic cancer‐derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP‐1 signaling pathways.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1628, doi. 10.1002/1878-0261.13442

By:

Chang, Yu‐Ting;
Peng, Hsuan‐Yu;
Hu, Chun‐Mei;
Tien, Sui‐Chih;
Chen, Yi‐Ing;
Jeng, Yung‐Ming;
Chang, Ming‐Chu

Publication type:

Article

Genomic and immune characteristics of HER2‐mutated non‐small‐cell lung cancer and response to immune checkpoint inhibitor‐based therapy.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1581, doi. 10.1002/1878-0261.13439

By:

Tu, Hai‐Yan;
Yin, Kai;
Zhao, Xiaotian;
Ke, E‐E;
Wu, Si‐Pei;
Li, Yang‐Si;
Zheng, Mei‐Mei;
Liu, Si‐Yang Maggie;
Xu, Chong‐Rui;
Sun, Yue‐Li;
Lin, Jia‐Xin;
Bai, Xiao‐Yan;
Zhang, Yi‐Chen;
Zhou, Qing;
Yang, Jin‐Ji;
Zhong, Wen‐Zhao;
Wang, Bing‐Chao;
Zhang, Xu‐Chao;
Zhu, Dongqin;
Yang, Lingling

Publication type:

Article

The invariant chain CD74 protein is a cell surface binding partner of TIMP‐1 in breast cancer cells.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1595, doi. 10.1002/1878-0261.13436

By:

Høeberg, Mikkel;
Noer, Julie Boertmann;
Vistesen, Mette Vixø;
Bartels, Annette;
Bech, Esben Matzen;
Nygård, Sune Boris;
Lademann, Ulrik;
Stenvang, Jan;
Liu, Siqi;
Fuglsang, Anja Thoe;
Brünner, Nils;
Moreira, José Manuel Afonso

Publication type:

Article

Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1648, doi. 10.1002/1878-0261.13429

By:

Wong, Sze‐Ching;
Yeh, Chun‐Chieh;
Zhang, Xun‐Yu;
Hsieh, Chih‐Ying;
Lo, Chia‐Chien;
Kuo, Ting‐Ting;
Lin, Ching‐Chan;
Chao, Chih‐Hua;
Liu, Jing‐Pei;
Chang, Ling‐Chu;
Wang, Lu‐Hai;
Sher, Yuh‐Pyng

Publication type:

Article

NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1613, doi. 10.1002/1878-0261.13422

By:

Lu, Yu‐Chuan;
Ho, Chen‐Hsun;
Hong, Jian‐Hua;
Kuo, Ming‐Chieh;
Liao, Yi‐An;
Jaw, Fu‐Shan;
Cheng, Jason Chia‐Hsien;
Huang, Chao‐Yuan;
Chang, Ko‐Ping;
Chen, Chung‐Hsin;
Lin, Jung‐An;
Hsiao, An;
Kung, Hsiu‐Ni

Publication type:

Article

LIM domain‐containing protein Ajuba inhibits chemotherapy‐induced apoptosis by negatively regulating p53 stability in colorectal cancer cells.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1678, doi. 10.1002/1878-0261.13421

By:

Xu, Beihui;
Li, Qi;
Zhang, Jianjun;
Chen, Fuxiang

Publication type:

Article

Immune escape of colorectal tumours via local LRH‐1/Cyp11b1‐mediated synthesis of immunosuppressive glucocorticoids.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1545, doi. 10.1002/1878-0261.13414

By:

Ahmed, Asma;
Reinhold, Cindy;
Breunig, Eileen;
Phan, Truong San;
Dietrich, Lea;
Kostadinova, Feodora;
Urwyler, Corinne;
Merk, Verena M.;
Noti, Mario;
Toja da Silva, Israel;
Bode, Konstantin;
Nahle, Fatima;
Plazzo, Anna Pia;
Koerner, Julia;
Stuber, Regula;
Menche, Constantin;
Karamitopoulou, Eva;
Farin, Henner F.;
Gollob, Kenneth J.;
Brunner, Thomas

Publication type:

Article

Improved detection of homologous recombination deficiency in Chinese patients with ovarian cancer: a novel non‐exonic single‐nucleotide polymorphism‐based next‐generation sequencing panel.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1666, doi. 10.1002/1878-0261.13411

By:

Wei, Bing;
Zheng, Jinxiang;
Jiang, Cai;
Zhang, He;
Zhang, Mingye;
Cheng, Taoran;
Li, Jun;
Wang, Zhizhong;
Deng, Lijun;
Wang, Li;
Xia, Qingxin;
Ma, Jie

Publication type:

Article

Resistance prediction in high‐grade serous ovarian carcinoma with neoadjuvant chemotherapy using data‐independent acquisition proteomics and an ovary‐specific spectral library.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1567, doi. 10.1002/1878-0261.13410

By:

Qian, Liujia;
Zhu, Jianqing;
Xue, Zhangzhi;
Gong, Tingting;
Xiang, Nan;
Yue, Liang;
Cai, Xue;
Gong, Wangang;
Wang, Junjian;
Sun, Rui;
Jiang, Wenhao;
Ge, Weigang;
Wang, He;
Zheng, Zhiguo;
Wu, Qijun;
Zhu, Yi;
Guo, Tiannan

Publication type:

Article

Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8<sup>+</sup> T cells.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1514, doi. 10.1002/1878-0261.13403

By:

Wang, Mengyao;
Zhai, Rundong;
Wang, Mengqi;
Zhu, Weiwen;
Zhang, Jiayi;
Yu, Miao;
Zhang, Wei;
Ye, Jinhai;
Liu, Laikui

Publication type:

Article

Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T‐cell receptor sequencing.

Published in:

Molecular Oncology, 2023, v. 17, n. 8, p. 1531, doi. 10.1002/1878-0261.13381

By:

Huang, Jin;
Zhao, Guofeng;
Peng, Qiu;
Yi, Xin;
Ji, Liyan;
Li, Jing;
Li, Pansong;
Guan, Yanfang;
Ge, Jie;
Chen, Ling;
Chen, Runzhe;
Hu, Xin;
Lee, Won‐Chul;
Reuben, Alexandre;
Futreal, P. Andrew;
Xia, Xuefeng;
Ma, Jian;
Zhang, Jianjun;
Chen, Zihua

Publication type:

Article

Issue Information.

Published in:: Molecular Oncology, 2023, v. 17, n. 8, p. 1455, doi. 10.1002/1878-0261.13238
Publication type:: Article